Øystein Fluge - Concepedia

Author

Øystein Fluge

Also Known As

Fluge, Ø, Fluge, Øystein, Linda Fauske, O Fluge, O. Fluge, Oystein Fluge, Pollack, Jonathan R., for the Norwegian Gastrointestinal Cancer Group, ystein Fluge, Ø FLUGE

133

Publications

19.8K

Citations

H-Index

Concepts

All Affiliations

Haukeland University Hospital University of Bergen Oslo University Hospital University of Oslo University Hospital of North Norway

ØF

About

Øystein Fluge is an author at Haukeland University Hospital specializing in medicine, health sciences, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	18	17.3K
2	Health Sciences	6	6	674
3	Engineering	1	1	29
4	Natural Sciences	1	1	24
5	Public Health	1	1	50

Øystein Fluge

Publications

18.7K

Citations

H-Index

Page 1

	Year	Citations
Molecular portraits of human breast tumours Charles M. Perou, Thérese Sørlie, Michael B. Eisen, Nature Breast OncologyEndocrine-related CancerPathologyBreast CancerMedicine	2000	16.1K
Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome Madlen Loebel, Patricia Grabowski, Harald Heidecke, Brain Behavior and Immunity Immune RegulationImmunologyImmune SystemImmune DysregulationRituximab Maintenance Treatment	2015	240
Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome Øystein Fluge, Olav Mella, Ove Bruland, JCI Insight Metabolic SyndromeEnergy MetabolismAmino Acid PatternBiochemistryAmino Acids	2016	201
Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study Øystein Fluge, Ove Bruland, Kristin Risa, PLoS ONE	2011	196
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide G. Dresemann, Michael Weller, Mark Rosenthal, Journal of Neuro-Oncology Neuro-oncologyOncologyMedicineGlioblastoma ResistantDose Temozolomide	2009	153
Upregulated PDK4 expression is a sensitive marker of increased fatty acid oxidation Ina Katrine Nitschke Pettersen, Deusdedit Tusubira, Hanan Ashrafi, Mitochondrion Pdk4 ExpressionMitochondrial BiologyMetabolic RemodelingFatty Acid OxidationOxidative Stress	2019	143
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment Øystein Fluge, Kristin Risa, Sigrid Lunde, PLoS ONE	2015	124
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma Leo Meriranta, Amjad Alkodsi, Annika Pasanen, Blood	2021	121
Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study Harald Holte, Sirpa Leppä, Magnus Björkholm, Annals of Oncology Hematological MalignancyNeuro-oncologyDose-densified ChemoimmunotherapyLymphoid NeoplasiaOncology	2012	116
B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Øystein Fluge, Ingrid G. Rekeland, Katarina Lien, Annals of Internal Medicine	2019	88

Page 1